UMIN-CTR Clinical Trial

Public title

Development of Curriculum for Community Medicine Based Screening for Arrhythmia

Acronym

Development of Curriculum for Community Medicine Based Screening for Arrhythmia

Scientific Title

Development of Curriculum for Community Medicine Based Screening for Arrhythmia

Scientific Title:Acronym

Development of Curriculum for Community Medicine Based Screening for Arrhythmia

Region

Japan

Condition

arrhythmia

Classification by specialty

Cardiology

Geriatrics

Classification by malignancy

Others

Genomic information

NO

Narrative objectives1

In Japan, a super-aging society has been developed, and advanced medical care and community medical care "healing and supporting medical care" have progressed in cooperation from hospital-centered "healing medical care". While advanced medical care is highly specialized for treatment of critically ill patients in advanced treatment hospitals, regional medical care such as disease prevention, mild illness treatment, and home care is based on community-institutions. Education and production of high-quality and leading next-generation pharmacists who can respond to such medical reforms is one of the major missions imposed on the faculty of pharmacy.
Recent progress in hospital training curriculums are remarkable, but on the other hand, there are few opportunities for students to be actively involved in disease prevention and health promotion of local residents, and there are few educational curricula to teach them. Therefore, the development of next-generation pharmacy education of community medicine curriculum is essential.
Since myocardial infarction and stroke facilitate mortality, screening is essential as part of disease prevention. In Japan, it is rare to have a health fair led by a student at the Faculty of Pharmaceutical Sciences, so the method of the health fair and clinical research methods based on the data obtained from the fair are not well known. The University of New Mexico, School of Pharmacy has already hosted many student-led health fairs that contribute to community medicine by screening for various diseases.
Therefore, in this project, a student-led health fair is held, and these methods are shared by the three organizations of the University of New Mexico, Nagasaki University, and the Nagasaki Prefectural Pharmacists Association.

Basic objectives2

Others

Basic objectives -Others

We investigate the prevalence of arrhythmia in Nagasaki citizens in the health fare.

Trial characteristics_1

Trial characteristics_2

Developmental phase

Primary outcomes

A questionnaire survey will be conducted on subjects, students, pharmacists, and teachers who participated in cardiac arrhythmia screening events to investigate the benefits of this educational program.
We will analyze the prevalence rate of arrhythmia rate in Nagasaki citizens.

Key secondary outcomes

Study type

Observational

Basic design

Randomization

Randomization unit

Blinding

Control

Stratification

Dynamic allocation

Institution consideration

Blocking

Concealment

No. of arms

Purpose of intervention

Type of intervention

Interventions/Control_1

Interventions/Control_2

Interventions/Control_3

Interventions/Control_4

Interventions/Control_5

Interventions/Control_6

Interventions/Control_7

Interventions/Control_8

Interventions/Control_9

Interventions/Control_10

Age-lower limit

18

years-old

<=

Age-upper limit

Not applicable

Gender

Male and Female

Key inclusion criteria

No

Key exclusion criteria

No

Target sample size

384

Name of lead principal investigator

1st name	Mana
Middle name
Last name	Miyakoda

Organization

Nagasaki University

Division name

School of Pharmaceutical Sciences

Zip code

852-8521

Address

1-14 Bunkyo-machi, Nagasaki City

TEL

095-819-2456

Email

mana-t@nagasaki-u.ac.jp

Name of contact person

1st name	Mana
Middle name
Last name	Miyakoda

Organization

Nagasaki University

Division name

School of Pharmaceutical Sciences

Zip code

852-8521

Address

1-14 Bunkyo-machi, Nagasaki City

TEL

095-819-2456

Homepage URL

Email

mana-t@nagasaki-u.ac.jp

Institute

Nagasaki University

Institute

Department

Personal name

Organization

Nagasaki University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Co-sponsor

Name of secondary funder(s)

Organization

Nagasaki University Graduate School of Biomedical Science

Address

1-12-4 Sakamoto-machi, Nagasaki City

Tel

095-819-7198

Email

gakujutu_gakuji@ml.nagasaki-u.ac.jp

Secondary IDs

NO

Study ID_1

Org. issuing International ID_1

Study ID_2

Org. issuing International ID_2

IND to MHLW

Institutions

Date of disclosure of the study information

2019

Year

10

Month

04

Day

URL releasing protocol

Publication of results

Unpublished

URL related to results and publications

Number of participants that the trial has enrolled

40

Results

Results date posted

Results Delayed

Results Delay Reason

Date of the first journal publication of results

Baseline Characteristics

Participant flow

Adverse events

Outcome measures

Plan to share IPD

IPD sharing Plan description

Recruitment status

Completed

Date of protocol fixation

2019

Year

10

Month

04

Day

Date of IRB

2019

Year

09

Month

24

Day

Anticipated trial start date

2019

Year

10

Month

04

Day

Last follow-up date

2022

Year

03

Month

31

Day

Date of closure to data entry

Date trial data considered complete

Date analysis concluded

Other related information

Sunday, October 6, 2019, 12: 00-15: 00, a rapid test for arrhythmia will be conducted at Coco Square in Cocowalk-Nagasaki, a shopping mall in Mori-machi, Nagasaki City. We will analyze the prevalence of arrhythmia in Nagasaki citizens using the collected data. In addition, a questionnaire survey is conducted for pharmacists and pharmacy students to examine if this event is useful as a curriculum.

Registered date

2019

Year

10

Month

04

Day

Last modified on

2022

Year

10

Month

06

Day

Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043530